PEGZX
Price
$23.24
Change
+$0.02 (+0.09%)
Updated
Nov 13 closing price
RPTIX
Price
$112.99
Change
-$0.33 (-0.29%)
Updated
Nov 13 closing price
Ad is loading...

PEGZX vs RPTIX

Header iconPEGZX vs RPTIX Comparison
Open Charts PEGZX vs RPTIXBanner chart's image
PGIM Jennison Mid-Cap Growth Z
Price$23.24
Change+$0.02 (+0.09%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$112.99
Change-$0.33 (-0.29%)
VolumeN/A
CapitalizationN/A
PEGZX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEGZX vs. RPTIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEGZX is a Buy and RPTIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 32B vs. PEGZX (2.64B). RPTIX pays higher dividends than PEGZX: RPTIX (0.18) vs PEGZX (0.00). PEGZX was incepted earlier than RPTIX: PEGZX (28 years) vs RPTIX (9 years). PEGZX is a more actively managed with annual turnover of: 38.00 vs. RPTIX (21.70). PEGZX has a lower initial minimum investment than RPTIX: PEGZX (0) vs RPTIX (500000). PEGZX annual gain was more profitable for investors over the last year : 27.23 vs. RPTIX (21.29). RPTIX return over 5 years is better than : 18.66 vs. PEGZX (-30.10).
PEGZXRPTIXPEGZX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years9 years-
Gain YTD15.86813.037122%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B32B8%
Annual Yield % from dividends0.000.18-
Returns for 1 year27.2321.29128%
Returns for 3 years-25.00-14.64171%
Returns for 5 years-30.1018.66-161%
Returns for 10 years-46.71N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNMD74.77-0.09
-0.12%
CONMED Corp
DOX92.71-0.15
-0.16%
Amdocs Limited
TERN7.17-0.29
-3.89%
Terns Pharmaceuticals
AUUD0.57-0.06
-8.93%
Auddia
EBS10.89-1.08
-9.02%
Emergent Biosolutions